UPDATED Apr 20, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
BAS.BH | BD$2.49 | 0% | n/a | BD$12.3m | n/a | PE10.7x | n/a | 0% | ||
7857 | JP¥1,320.00 | 0.4% | -2.2% | JP¥5.5b | n/a | PE15.4x | n/a | 1.8% | ||
CETG | €404.00 | 0% | n/a | €80.8m | n/a | PE4.3x | n/a | 7.4% | ||
SUG | AU$1.10 | 0.5% | 2.8% | AU$394.2m | n/a | PE13x | n/a | 7.3% | ||
LQDT | US$17.05 | -4.8% | 24.4% | US$523.8m | US$27.50 | PE27.7x | E26.2% | n/a | ||
BRC | US$58.65 | -0.4% | 11.8% | US$2.8b | US$68.50 | PE15.1x | E5.2% | 1.6% | ||
1631 | HK$0.34 | 4.5% | -6.8% | HK$88.3m | n/a | PE7.5x | n/a | 0% | ||
E7 | د.إ11.24 | -4.1% | n/a | د.إ2.2b | n/a | PS3.6x | n/a | n/a | ||
1324 | NT$15.15 | 3.4% | 32.9% | NT$1.1b | n/a | PE28.8x | n/a | 1.3% | ||
2325 | JP¥3,020.00 | -2.6% | 34.6% | JP¥28.8b | n/a | PE14.4x | n/a | 3.0% | ||
1438 | JP¥1,940.00 | 1.0% | 79.3% | JP¥6.2b | n/a | PE19x | n/a | 1.5% | ||
7912 | JP¥4,414.00 | -3.0% | 15.2% | JP¥1.1t | JP¥5,116.67 | PE8.8x | E-7.8% | 1.4% | ||
6093 | JP¥139.00 | -3.5% | -2.8% | JP¥6.1b | n/a | PE20.3x | n/a | 2.9% | ||
HHHCORP | RM0.15 | -6.3% | 7.1% | RM59.3m | n/a | PE7.6x | n/a | n/a | ||
4345 | JP¥730.00 | -3.7% | -6.3% | JP¥30.9b | JP¥900.00 | PE16.4x | E7.6% | 3.4% | ||
1127 | HK$1.29 | -1.5% | 9.3% | HK$993.3m | n/a | PE5.4x | n/a | 8.5% | ||
GENCO | ฿0.50 | -2.0% | -21.9% | ฿554.4m | n/a | PS2x | n/a | 0% | ||
REMM | RON17.20 | 0% | n/a | RON5.3m | n/a | PE3.3x | n/a | 0% | ||
1955 | HK$0.47 | 9.4% | -32.6% | HK$232.5m | n/a | PE37.1x | n/a | 2.6% | ||
5695 | JP¥2,272.00 | -2.6% | 2.7% | JP¥6.6b | n/a | PE24.4x | n/a | 4.0% | ||
8472 | HK$0.52 | -1.9% | -63.9% | HK$49.9m | n/a | PE3.6x | n/a | n/a | ||
1540 | HK$0.45 | -4.3% | 8.4% | HK$224.4m | n/a | PE6.7x | n/a | 8.9% | ||
523207 | ₹127.45 | 0.8% | 74.4% | ₹12.8b | n/a | PE30.3x | n/a | 0.4% | ||
6663 | HK$0.33 | -2.9% | -27.5% | HK$264.0m | n/a | PE17x | n/a | 4.5% |